[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Bio Stocks™ [@BioStocks](/creator/twitter/BioStocks) on x 68.6K followers Created: 2025-07-10 11:39:03 UTC $ABBV and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody. IGI will receive an upfront payment of $700M + up to $1.25B in milestone payments. XXXXXX engagements  **Related Topics** [$125b](/topic/$125b) [$700m](/topic/$700m) [stocks](/topic/stocks) [$abbv](/topic/$abbv) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/BioStocks/status/1943273759906902309)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Bio Stocks™ @BioStocks on x 68.6K followers
Created: 2025-07-10 11:39:03 UTC
$ABBV and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody.
IGI will receive an upfront payment of $700M + up to $1.25B in milestone payments.
XXXXXX engagements
Related Topics $125b $700m stocks $abbv stocks healthcare
/post/tweet::1943273759906902309